Patent Yard Sign in
Canadian application, no grantCanada

Novel sulfonamide derivatives

CA 2289517 A1 · Owner: Nippon Kayaku Kabushiki Kaisha · Inventors: Morohashi, Hirohisa; Sato, Hiroshi

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Sulfonamide derivatives represented by general formula (1) or pharmaceutically acceptable salts thereof, which have little toxicity and a potent effect of inhibiting tubulin polymerization wherein R1 preferably represents lower alkoxy; R2, R3, R4, R5 and R6 may be the same or different and each independently represents hydrogen, halogeno nitro, lower alkyl, optionally , substituted amino or alkylamino; A represents: (1) a 5-membered heterocyclic group having at least one nitrogen atom which may be substituted and contain as the heteroatom an atom selected from among nitrogen oxygen and sulfur, provided that triazole is excluded therefrom; (2) an optionally substituted alicyclic …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 29, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 29, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 29, 1998
GrantedNo grant recorded
Term endedMay 29, 2018
Patent numberCA 2289517 A1
Classification (IPC)C07C311/46 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedMay 29, 1998Term endedMay 29, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.